Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biora Therapeutics Inc BIOR

Healthcare Biotechnology
Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and systemic, needle-free delivery of biotherapeutics. The Company’s pipeline includes two therapeutic delivery platforms: NaviCap and BioJet. The NaviCap, targeted oral delivery platform, which is designed to improve outcomes for... see more

Recent & Breaking News (NDAQ:BIOR)

Progenity Receives Funding from Crohn's & Colitis Foundation IBD Ventures Fund to Develop Drug Delivery System for IBD

GlobeNewswire May 11, 2021

Progenity to Report First Quarter 2021 Financial Results and Provide Corporate Update

GlobeNewswire May 6, 2021

Progenity Provides Key Update Regarding its Preecludia(TM) Test for Preeclampsia

GlobeNewswire May 5, 2021

Progenity Presents Key Verification Study Data for Preecludia(TM) Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting

GlobeNewswire April 30, 2021

Progenity to Present Two Abstracts for Novel Ingestible Drug Delivery Technologies at Digestive Disease Week 2021

GlobeNewswire April 26, 2021

Progenity to Present Key Prospective Verification Study Data for its Preeclampsia Rule-Out Test at 2021 American College of Obstetricians and Gynecologists Annual Meeting

GlobeNewswire April 8, 2021

Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity's Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies

GlobeNewswire April 6, 2021

Johnson Fistel Investigates Progenity; Should Management be Held Accountable for Investors Losses?

PR Newswire March 27, 2021

NOTICE For Investors In NASDAQ: PROG Shareholder Notice: Update in Lawsuit against Progenity, Inc. announced by Shareholders Foundation

Newsfile March 23, 2021

Progenity Provides Corporate Updates and Reports Fourth Quarter and Full-Year 2020 Financial Results

GlobeNewswire March 18, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

Newsfile March 14, 2021

Progenity to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update

GlobeNewswire March 12, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

ACCESSWIRE IA March 10, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

Newsfile March 7, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

Canada NewsWire March 3, 2021

Progenity Announces $25 Million Private Placement

GlobeNewswire February 23, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Progenity, Inc. - PROG

Newsfile February 22, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

PR Newswire February 19, 2021

Progenity Initiates Safety and Tolerability Study of its Smart Capsule-Based Oral Drug Delivery System for GI Diseases

GlobeNewswire February 17, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG

Newsfile February 15, 2021